Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2025-12-03 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
关于取得2项发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instrument Co., Ltd. about obtaining two invention patent certificates. It includes patent numbers, application dates, and the impact of these patents on the company. There is no financial data, regulatory filing references, or report publication statements. The content is about intellectual property achievements, which does not fit into any financial report or regulatory filing categories. Since it is an announcement about patents, it does not match any of the specific filing categories related to financial or corporate governance reports. Therefore, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other categories.
2025-12-03 Chinese
关于取得3项发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. about obtaining three invention patent certificates. It includes patent numbers, application dates, and authorization dates. The content focuses on intellectual property achievements and their impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no management changes, no voting results, no legal proceedings, and no other categories related to financial or governance reports. The document is a regulatory announcement about patents, which does not fit into any specific financial report category. Therefore, it falls under the fallback category Regulatory Filings (RNS). The document length is short and it is a standalone announcement, not a report or presentation.
2025-11-25 Chinese
关于使用闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instrument Co., Ltd. regarding the progress of using idle self-owned funds to purchase financial products. It details the authorization, amounts, counterparties, risk controls, and status of these financial products. The content is focused on capital management and financing activities, specifically the use of idle funds for investment in financial products. There is no indication that this is a full financial report, audit report, or earnings release. It is not a regulatory filing or a report publication announcement since it contains substantive information about the financing activity. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2025-11-09 Chinese
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instrument Co., Ltd. regarding the progress of using idle raised funds for cash management. It details the board meeting approval, the amount and types of financial products purchased with the idle funds, risk controls, and disclosures as per the Beijing Stock Exchange rules. The document is a disclosure about the company's cash management activities involving idle raised funds, including amounts, counterparties, and risk management, but it does not contain financial statements or comprehensive financial performance data. It is not a full financial report, earnings release, or management discussion. It is a regulatory announcement about capital/financing activities related to the use of raised funds for cash management. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters, but it is a substantive disclosure, not merely a report publication announcement or a certification. Hence, CAP is the best fit with high confidence.
2025-11-02 Chinese
第四届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 11th meeting of the 4th Board of Directors of Shanghai Boxun Medical Biological Instruments Co., Ltd. It includes details about the meeting date, attendance, and the approval of specific proposals such as the 2025 Q3 report and a credit application to a bank. The document references the actual 2025 Q3 report and credit announcement as being disclosed separately on the Beijing Stock Exchange information platform, indicating this document is not the report itself but an announcement of board decisions. The content is focused on board meeting resolutions rather than the full financial report or detailed financial data. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2025-10-29 Chinese
关于向银行申请授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a bank credit facility (授信额度). It details the credit amount, purpose, board approval, and authorization for management to execute related contracts. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (1011 characters) and serves as a formal notice of financing activity rather than a full financial report or earnings release. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising or financing activities.
2025-10-29 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.